BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2787820)

  • 1. Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery.
    Simsek H; Schuman BM
    J Clin Gastroenterol; 1989 Jun; 11(3):294-8. PubMed ID: 2787820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.
    Click B; Ramos Rivers C; Koutroubakis IE; Babichenko D; Anderson AM; Hashash JG; Dunn MA; Schwartz M; Swoger J; Baidoo L; Barrie A; Regueiro M; Binion DG
    Inflamm Bowel Dis; 2016 Jun; 22(6):1442-9. PubMed ID: 26950309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
    Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
    World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.
    Moum B; Ekbom A; Vatn MH; Aadland E; Sauar J; Lygren I; Schulz T; Stray N; Fausa O
    Scand J Gastroenterol; 1997 Oct; 32(10):1005-12. PubMed ID: 9361173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of inflammatory bowel disease on post-cholecystectomy complications and hospitalization costs: a Nationwide Inpatient Sample study.
    Navaneethan U; Parasa S; Venkatesh PG; Ganapathi TT; Kiran RP; Shen B
    J Crohns Colitis; 2013 Jun; 7(5):e164-70. PubMed ID: 22959005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
    Sofia MA; Rubin DT; Hou N; Pekow J
    Dig Dis Sci; 2014 Sep; 59(9):2228-35. PubMed ID: 24752402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis and its relationship to the colon in a black cohort of inflammatory bowel disease patients.
    Koczka CP; Geraldino-Pardilla LB; Lawlor G
    J Clin Gastroenterol; 2014 Feb; 48(2):e19-21. PubMed ID: 24402121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
    Nguyen GC; Torres EA; Regueiro M; Bromfield G; Bitton A; Stempak J; Dassopoulos T; Schumm P; Gregory FJ; Griffiths AM; Hanauer SB; Hanson J; Harris ML; Kane SV; Orkwis HK; Lahaie R; Oliva-Hemker M; Pare P; Wild GE; Rioux JD; Yang H; Duerr RH; Cho JH; Steinhart AH; Brant SR; Silverberg MS
    Am J Gastroenterol; 2006 May; 101(5):1012-23. PubMed ID: 16696785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
    J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.